Abvc Biopharma Inc ABVC

$0.91 -0.05 (-5.56%)

Valuation

Market cap
25,995,000
Revenue TTM
$0
Net income TTM
$-7,910,000
P/E (trailing)
0.00
P/E (forward)
—
Profit margin
0.00%
Debt to equity
0.00

Trading

Volume
38,100
Avg volume
80,826
Day's range
$0.86 – $0.98
Shares out
26,977,000
Stochastic %K
23%
Beta
0.47
Analysts
—
Price target
$20.20

Price

Company profile

ABVC BioPharma, Inc., a clinical-stage biopharmaceutical company, develops drugs and medical devices to fulfill unmet medical needs in the United States. The company is developing ABV-1501, which is in Phase II clinical trials as a combination therapy for triple negative breast cancer; ABV-1504, which has completed Phase II clinical trials for depressive disorders; ABV-1505, which is in Phase II clinical trials for a...

Show more

ABVC BioPharma, Inc., a clinical-stage biopharmaceutical company, develops drugs and medical devices to fulfill unmet medical needs in the United States. The company is developing ABV-1501, which is in Phase II clinical trials as a combination therapy for triple negative breast cancer; ABV-1504, which has completed Phase II clinical trials for depressive disorders; ABV-1505, which is in Phase II clinical trials for adult attention deficit hyperactivity disorder; ABV-1702, which is in Phase II clinical trials to treat myelodysplastic syndromes; and ABV-1601, which is in Phase I/II clinical trials for treating depression in cancer patients. It is also developing ABV-1701 Vitargus, which is in Phase II clinical trials for the treatment of retinal detachment or vitreous hemorrhage; ABV-1519, which is in Phase I/II clinical trials for the treatment of non-small cell lung cancer; ABV-2001, an intraocular irrigation solution; ABV-2002, a corneal Storage Solution; and ABV-1703, which is in Phase II clinical trials for the treatment of metastatic pancreatic cancer. The company has a co-development agreement with Rgene Corporation and collaboration agreements with BioHopeKing Corporation and BioFirst Corporation. The company is based in Fremont, California.

Industry
Biotechnology
Sector
Healthcare
Phone
510 668 0881
Website
https://www.abvcpharma.com
Address
44370 Old Warm Springs Boulevard, Fremont, United States

Latest news

Stocktwits

Rayvio_News_Filter Nov 2, 3:00 PM
$ABVC 💰 ABVC BioPharma, Inc. closed a private placement of 17.5% original issue discount senior convertible promissory notes with aggregate principal amount of $4,106,060, generating gross proceeds of approximately $3.39 million. Selected from hundreds of headlines
1 replies
BigdollarMaker Oct 13, 7:46 PM
$BB $ABVC Dive in, there's money to be made here$$$$$
0 replies
CapitalWhale Oct 4, 11:22 PM
$ABVC No revenue in Q2 2026 and continued losses\/
0 replies
BigdollarMaker Sep 17, 2:48 PM
$BB $ABVC Oh yeah$$$$
0 replies
BigdollarMaker Sep 16, 4:37 PM
$ABVC Back to $1 now lets get back over
0 replies
BigdollarMaker Sep 4, 2:29 PM
$ABVC We need to get over, this is way too low for what we have!
0 replies
topstockalerts Aug 27, 8:39 PM
$ABVC this one is behaving like it has another chapter.
0 replies
BigdollarMaker Aug 27, 6:14 PM
$BB $ABVC Green feels good.
0 replies